OOIR: Observatory of International Research

Papers

(The TQCC of Pharmacotherapy is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Comment on “Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study”	74
Standards of practice to advance the quality of health care	69
Population pharmacokinetic model‐guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction	56
Correlation between heparin anti‐Xa activity and thromboelastography in adult critically ill COVID‐19 patients	39
	38
Empiric dosing strategies to predict lamotrigine concentrations during pregnancy	36
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the Am	34
Dosing implications for liposomal amphotericin B in pregnancy	31
Enhancing pharmacokinetic and pharmacodynamic knowledge in pediatrics	30
Current clinical pharmacology issues in pregnancy and pediatrics	30
Association of atrial fibrillation with lamotrigine: An observational cohort study	29
Characterization of lamotrigine disposition changes during and after pregnancy in women with epilepsy	28
Issue Information	27
Issue Information	25
Comparison of risk‐scoring systems for heparin‐induced thrombocytopenia in cardiac surgery patients	25
	25
	24
The safety of rapid infusion levetiracetam: A systematic review	21
Myocardial infarction associated with erenumab: A case report	21
Thirty‐day risk of digoxin toxicity among older adults co‐prescribed trimethoprim‐sulfamethoxazole versus amoxicillin: A population‐based cohort study	21
Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection	20
Successful prolonged treatment of a carbapenem‐resistant Acinetobacter baumannii hip infection with cefiderocol: A case report	19
Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections	19
	17
Issue Information	17

Evaluation of the change in efficacy of erenumab when used long‐term for migraine prevention after initial established benefit in a veteran population	17
Issue Information	17
Impact of model‐informed precision dosing on achievement of vancomycin exposure targets in pediatric patients with cystic fibrosis	16
	15
Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction	15
Apixaban and rivaroxaban use for atrial fibrillation in patients with obesity and BMI ≥50 kg/m²	15
Optimizing rapid diagnostics and diagnostic stewardship in Gram‐negative bacteremia	15
Perioperative cangrelor in patients with recent percutaneous coronary intervention undergoing liver transplantation: A case series	14
Issue Information	14
Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta‐analysis	14
Impact of medication intensification on 30‐day hospital readmissions in a geriatric trauma population: A multicenter cohort study	14
	14
Issue Information	14
Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome	14
The incidence of torsades de pointes with peri‐operative low‐dose ondansetron administration	13
Comment on “The power and pitfalls of underpowered studies”	13
Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: Current evidence and knowledge gaps	13
Association of bleeding with serotonergic antidepressants in patients receiving left ventricular assist device support	13
A systematic review of direct acting antiviral therapies in hepatitis C virus‐negative liver transplant recipients of hepatitis C‐viremic donors	13
Expanded use of sodium‐glucose cotransporter 2 inhibitors: Evidence beyond heart failure with reduced ejection fraction	12
Restrictive resuscitation in patients with sepsis and mortality: A systematic review and meta‐analysis with trial sequential analysis	12
External evaluation of neonatal vancomycin population pharmacokinetic models: Moving from first‐order equations to Bayesian‐guided therapeutic monitoring	12
A pilot study of ADRA2A genotype association with doses of dexmedetomidine for sedation in pediatric patients	12
Warfarin dosage in a postpartum woman while breastfeeding: A case report	12
Administration of rabies immunoglobulin: Improving evidence‐based guidance for wound infiltration	12
Pilot and feasibility study of dietary composition with elexacaftor‐tezacaftor‐ivacaftor concentrations in people with cystic fibrosis	12
Changes in serum potassium in people with type 2 diabetes taking sodium‐glucose co‐transporter‐2 inhibitors	12
Personalizing prevention: Advances in pharmacotherapy for HIV prevention	12
Pediatric considerations for pharmacogenetic selective serotonin reuptake inhibitors clinical decision support	12
	11
Meta‐analysis of clinical outcomes of PCSK9 modulators in patients with established ASCVD	11
Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review	11
Renal function estimating equations performance during pregnancy and postpartum	11
Assessment and management of iatrogenic withdrawal syndrome and delirium in pediatric intensive care units across Europe: An ESPNIC survey	11
The association between urate‐lowering therapies and treatment‐related adverse events, liver damage, and major adverse cardiovascular events (MACE): A network meta‐analysis of randomized trials	10
The gray area of scientific adequacy	10
The role of tazobactam‐based combinations for the management of infections due to extended‐spectrum β‐lactamase‐producing Enterobacterales: Insights from the Society of Infectious Diseases Pharmacists	10
Corrigendum	10
Removing race and body surface area indexation for estimated kidney function based drug dosing: Aminoglycosides as justification of these principles	10
Real‐world effectiveness of monoclonal antibody inhibitors of PCSK9 in patients with heterozygous familial hypercholesterolemia: A retrospective cohort study	10
Association between household opioid prescriptions and risk for overdose among family members not prescribed opioids	10
Evolving resistance landscape in gram‐negative pathogens: An update on β‐lactam and β‐lactam‐inhibitor treatment combinations for carbapenem‐resistant organisms	10
Low‐dose adjuvant dexmedetomidine did not decrease propofol sedation requirements in children undergoing gastrointestinal endoscopy	10
Trends in the appropriateness of oral antibiotic prescriptions dispensed in the United States from 2010 to 2018	10
Effectiveness of sacubitril/valsartan versus aldosterone antagonists in heart failure with reduced ejection fraction: A retrospective cohort study	10
Precision fluid and vasoactive drug therapy for critically ill patients	9
Contribution of pharmaceutical drugs of dependence to the incidence of neonatal abstinence syndrome in Western Australia between 2003 and 2018	9
Update and narrative review of avian influenza (H5N1) infection in adult patients	9
Associating regulatory actions on diclofenac use with Danish trends in utilization by route of administration 1999–2023	9
Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect	8

Glucagon: Its evolving role in the management of hypoglycemia	8
Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients	8
Current pharmacotherapy management of children and adults with pericarditis: Prospectus for improved outcomes	8
Issue Information	8
Treatment of patients with serious infections due to carbapenem‐resistant Acinetobacter baumannii: How viable are the current options?	8
Systematic review and meta‐analysis of the correlation between bispectral index (BIS) and clinical sedation scales: Toward defining the role of BIS in critically ill patients	8
Precision‐based approaches to delirium in critical illness: A narrative review	8
A prospective study of filgrastim pharmacokinetics in morbidly obese patients compared with non‐obese controls	8
Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the I	8
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review	8
Exploring the frontier of cardiovascular pharmacotherapy	8
Issue Information	8
Systematic literature review of insulin dose adjustments when initiating hemodialysis or peritoneal dialysis	7
Novel and replicated clinical and genetic risk factors for toxicity from high‐dose methotrexate in pediatric acute lymphoblastic leukemia	7
	7
Metformin use is associated with reduced acute kidney injury following coronary artery bypass grafting in patients with type 2 diabetes: An inverse probability of treatment weighting analysis	7
Disease‐modifying therapies for amyloid transthyretin cardiomyopathy: Current and emerging medications	7
Impact of proton pump inhibitors on sustained virologic response in veterans treated with sofosbuvir/velpatasvir for chronic hepatitis C virus: A retrospective cohort study	7
Issue Information	7
Path of least recurrence: A systematic review and meta‐analysis of fidaxomicin versus vancomycin for Clostridioides difficile infection	7
The potential role of GLP‐1 receptor agonists in osteoarthritis	7
Reflections on the future of biomedical publishing	6
A systematic review of opioid use and multimodal strategies in solid organ transplant recipients and living donors	6
	6
Therapeutic review of cabotegravir/rilpivirine long‐acting antiretroviral injectable and implementation considerations at an HIV specialty clinic	6
Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens	6
Pharmacogenetics ofP2Y₁₂receptor inhibitors	6
Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant	6
Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”	6
Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers	6
Fracture risk and opioid use in patients aged 17–64 years: An analysis of administrative claims data	6
Patient safety outcomes for continuous infusion vancomycin as outpatient parenteral antimicrobial therapy	6
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorse	5
Issue Information	5
Drug repurposing of dextromethorphan as a cellular target for the management of influenza	5
Impact of pre‐lung transplant statin use on the development of primary graft dysfunction	5
TT genotype of the MMP‐9‐1562C/T polymorphism may be a risk factor for thrombolytic therapy‐induced hemorrhagic complications after acute ischemic stroke	5
Safety of elexacaftor/tezacaftor/ivacaftor dose reduction: Mechanistic exploration through physiologically based pharmacokinetic modeling and a clinical case series	5
Use of therapeutic drug monitoring to characterize cefepime‐related neurotoxicity	5
Evaluation of anti‐factor Xa concentrations using a body mass index‐based enoxaparin dosing protocol for venous thromboembolism prophylaxis in trauma patients	5
Issue Information	5
Effects of aging on clinical outcomes in patients receiving genotype‐guided P2Y12 inhibitor selection after percutaneous coronary intervention	5
Issue Information	5
Physiologically based pharmacokinetic models for predicting lamotrigine exposure and dose optimization in pediatric patients receiving combination therapy with carbamazepine or valproic acid	5
GLP‐1RA‐induced delays in gastrointestinal motility: Predicted effects on coadministered drug absorption by PBPK analysis	5
Reduced risk of NSAID‐Induced adverse events with concomitant use of misoprostol (MICRO study)	5
Emerging therapies for eosinophilic esophagitis	5
Response to comment on “Dosing implications for liposomal amphotericin B in pregnancy”	5
Elbasvir/grazoprevir administered for 12 weeks via percutaneous endoscopic gastrostomy tube achieves sustained virologic response: A case report and a review of the literature	5
Randomized controlled trial to compare safety and efficacy of mycophenolate vs. cyclosporine after rituximab in children with steroid‐resistant nephrotic syndrome	5
Efficacy and safety of mirikizumab compared with currently approved biologic drugs for the treatment of ulcerative colitis: A systematic review and network meta‐analysis	5
Role of maternal COVID‐19 vaccination in providing immunological protection to the newborn	5